BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 11149740)

  • 1. Resolution of psoriasis after allogeneic bone marrow transplantation for chronic myelogenous leukemia: late complications of therapy.
    Adkins DR; Abidi MH; Brown RA; Khoury H; Goodnough LT; Vij R; Westervelt P; DiPersio JF
    Bone Marrow Transplant; 2000 Dec; 26(11):1239-41. PubMed ID: 11149740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of psoriasis following allogeneic bone marrow transplantation for chronic myelogenous leukemia: case report and review of the literature.
    Kanamori H; Tanaka M; Kawaguchi H; Yamaji S; Fujimaki K; Tomita N; Fujisawa S; Ishigatsubo Y
    Am J Hematol; 2002 Sep; 71(1):41-4. PubMed ID: 12221673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unexpected late graft failure 9 months after HLA-identical bone marrow transplant (BMT) for chronic myeloid leukemia (CML): treatment with a second BMT.
    Gil-Fernández JJ; Arranz R; Cámara R; Alegre A; Figuera A; Fernández-Rañada JM
    Haematologica; 1998 Mar; 83(3):285-7. PubMed ID: 9580418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resolution of immune-mediated diseases following allogeneic bone marrow transplantation for leukaemia.
    Yin JA; Jowitt SN
    Bone Marrow Transplant; 1992 Jan; 9(1):31-3. PubMed ID: 1543947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phimosis as a manifestation of chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Kami M; Kanda Y; Sasaki M; Takeda N; Tanaka Y; Saito T; Ogawa S; Honda H; Chiba S; Mitani K; Hirai H; Yazaki Y
    Bone Marrow Transplant; 1998 Apr; 21(7):721-3. PubMed ID: 9578313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory chronic GVHD emerging after splenectomy in a marrow transplant recipient with accelerated phase CML.
    Rodrigues CA; Fermino FA; Vasconcelos Y; de Oliveira JS
    Bone Marrow Transplant; 2003 Aug; 32(3):333-5. PubMed ID: 12858207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graft-versus-host disease following interferon therapy for relapsed chronic myeloid leukaemia post-allogeneic bone marrow transplantation.
    Browett PJ; Nelson J; Tiwari S; Van de Water NS; May S; Palmer SJ
    Bone Marrow Transplant; 1994 Oct; 14(4):641-4. PubMed ID: 7858542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumococcal arthritis after allogeneic bone marrow transplantation.
    Schwella N; Schwerdtfeger R; Schmidt-Wolf I; Schmid H; Siegert W
    Bone Marrow Transplant; 1993 Aug; 12(2):165-6. PubMed ID: 8401365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Leukocyte transfusion as therapy of recurrent CML after allogenic bone marrow transplantation].
    Wiesneth M; Hertenstein B; Bunjes D; Novotny J; Stefanic M; Heinze B; Schreiner T; Kubanek B; Heimpel H; Arnold R
    Beitr Infusionsther Transfusionsmed; 1994; 32():276-80. PubMed ID: 9480108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reconstitution of the CD45RO(+) and CD20(+) lymphoid marrow population following allogeneic bone marrow transplantation for Ph(+) CML.
    Thiele J; Kvasnicka HM; Beelen DW; Welter A; Schneider S; Leder LD; Schaefer UW
    Bone Marrow Transplant; 2001 Feb; 27(4):425-31. PubMed ID: 11313672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumococcal pericarditis with cardiac tamponade in a patient with chronic graft-versus-host disease.
    Pérez Retortillo JA; Marco F; Richard C; Conde E; Manjón R; Bureo E; Iriondo A; Zubizarreta A
    Bone Marrow Transplant; 1998 Feb; 21(3):299-300. PubMed ID: 9489655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association with the presence of naive T cells in chronic myeloid leukemia patients after allogeneic human stem cell transplantation and the lower incidence of chronic graft-versus host disease and relapse.
    Wysoczanska B; Bogunia-Kubik K; Dlubek D; Jaskula E; Sok A; Drabczak-Skrzypek D; Sedzimirska M; Lange A
    Transplant Proc; 2007 Nov; 39(9):2898-901. PubMed ID: 18022011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders.
    Slavin S; Aker M; Shapira MY; Resnick I; Bitan M; Or R
    Clin Transpl; 2003; ():275-82. PubMed ID: 15387119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase.
    Elmaagacli AH; Runkel K; Steckel N; Opalka B; Trenschel R; Seeber S; Schaefer UW; Beelen DW
    Bone Marrow Transplant; 2001 Apr; 27(8):809-15. PubMed ID: 11477437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005].
    Faber E; Koza V; Vítek A; Mayer J; Sedlácek P; Zák P; Zapletalová J; Benesová K; Krejcová H; Steinerová K; Maresová I; Cetkovský P
    Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
    Liu QF; Sun J; Zhang Y; Liu XL; Xu D; Xu B; Feng R; Meng FY; Zhou SY
    Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia.
    Dilek I; Demirer T; Ustün C; Arat M; Koç H; Beksaç M; Erdi H; Anadolu R; Ozcan M; Ilhan O; Akan H
    Bone Marrow Transplant; 1998 Jun; 21(11):1159-61. PubMed ID: 9645582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report.
    Saikia TK; Parikh PM; Tawde S; Amare-Kadam PS; Rajadhyaksha S; Chhaya S
    Natl Med J India; 2004; 17(2):71-3. PubMed ID: 15141598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic bone marrow transplant for chronic myelogenous leukemia in a patient with multiple sclerosis.
    McAllister LD; Beatty PG; Rose J
    Bone Marrow Transplant; 1997 Feb; 19(4):395-7. PubMed ID: 9051253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.